Cancer Prehabilitation for Patients Starting from Active Treatment to Surveillance

被引:18
|
作者
Shun, Shiow-Ching [1 ]
机构
[1] Natl Taiwan Univ, Sch Nursing, 1 Jen Ai Rd,Sec 1, Taipei 10051, Taiwan
关键词
Cancer; care model; impairment; prehabilitation;
D O I
10.4103/2347-5625.178169
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
The purpose of this brief summary is to introduce the concept of cancer prehabilitation and the role of oncology nurses in prehabilitation care. Cancer prehabilitation has been defined by Sliver and Baima (2013) as "a process on the cancer continuum of care that occurs between the time of cancer diagnosis and the beginning of acute treatment." The evidence supports the notion that prehabilitation programs can improve physical and psychological health outcomes and decrease overall health care costs. The care model for cancer prehabilitation should include timely and efficient assessment throughout the care continuum with a focus on improving outcomes in cancer at every stage. During the cancer journey, three types of assessment with different aims are included: (1) prehabilitation assessment pretreatment, (2) rehabilitation assessment at early post treatment, and (3) health promotion assessment at the end of treatment. Specific prehabilitation assessment and interventions for treatment-related complications or major side-effects should be considered. Teaching, counseling, discharge planning, and coordination should also be part of an oncology nurse's role in cancer prehabilitation. It is suggested that cancer care managers or navigators be trained in the assessment of their patients' physical and psychological status once the cancer diagnosis has been identified and the patient has decided to receive active treatment, especially for those waiting for surgery at home. Oncology nurses could increase their competence with prehabilitation care by gaining knowledge about cancer-related treatments and their outcomes for specific cancers and by strengthening the ability to assess the functional status and psychological distress of their patients.
引用
收藏
页码:37 / 40
页数:4
相关论文
共 50 条
  • [1] Empowering Wellness: A Comprehensive Narrative Review of Cancer Prehabilitation from Treatment Onset to Surveillance
    Saleh, Ahmad Mahmoud
    Al Daragemeh, Aishah Ibraheem
    Abdel-Aziz, Hassanat R.
    MALAYSIAN JOURNAL OF MEDICAL SCIENCES, 2024, 31 (05): : 109 - 114
  • [2] Antiandrogen Treatment vs Active Surveillance for Patients With Prostate Cancer
    Halthore, Aditya N.
    Andriole, Gerald L.
    Goldstein, Michael
    JAMA ONCOLOGY, 2023, 9 (01) : 148 - 148
  • [3] CONVERSION FROM ACTIVE SURVEILLANCE TO ACTIVE TREATMENT FOR PROSTATE CANCER: A QUALITATIVE ANALYSIS
    Wallace, M.
    GERONTOLOGIST, 2009, 49 : 208 - 208
  • [4] Antiandrogen Treatment vs Active Surveillance for Patients With Prostate Cancer Reply
    Shore, Neal D.
    Cooperberg, Matthew R.
    Tomlins, Scott A.
    JAMA ONCOLOGY, 2023, 9 (01) : 150 - 151
  • [5] Active Surveillance or Active Treatment in Localized Prostate Cancer?
    Weissbach, Lothar
    Altwein, Jens
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2009, 106 (22): : 371 - I
  • [6] Treatment triggers for patients on active surveillance
    Hilton, William M.
    Parekh, Dipen J.
    NATURE REVIEWS UROLOGY, 2011, 8 (03) : 126 - 127
  • [7] Treatment triggers for patients on active surveillance
    William M. Hilton
    Dipen J. Parekh
    Nature Reviews Urology, 2011, 8 : 126 - 127
  • [8] Conversion from Active Surveillance to Active Treatment for Prostate Cancer: A Qualitative Analysis.
    Wallace, M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2010, 58 : 68 - 68
  • [9] Switching from active surveillance to treatment in prostate cancer - why and when?
    Ng, M. Y.
    Begum, S.
    Huang, H. H.
    Lau, K. O. W.
    Lee, L. S.
    BJU INTERNATIONAL, 2017, 119 : 36 - 36
  • [10] MRI VISIBILITY OF PROSTATE CANCER AS A PREDICTOR OF PATHOLOGICAL RECLASSIFICATION AND ACTIVE TREATMENT IN PATIENTS ON ACTIVE SURVEILLANCE
    Cei, Francesco
    Ramacciotti, Lorenzo Storino
    Leni, Riccardo
    Kaneko, Masatomo
    Jadvar, Delara
    Aron, Manju
    Duddalwar, Vinay
    Brembilla, Giorgio
    Esposito, Antonio
    De Cobelli, Francesco
    Cacciamani, Giovanni
    Gandaglia, Giorgio
    Salonia, Andrea
    Briganti, Alberto
    Montorsi, Francesco
    Gill, Inderbir
    Abreu, Andre
    JOURNAL OF UROLOGY, 2025, 213 (5S):